Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years — Stella

Home/Kawasaki Disease/Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years

View on ClinicalTrials.gov

Recruiting

Back to Kawasaki Disease trials

Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years

Trial locations(1 site)

China

Children's Hospital of Fudan University, Shanghai, Shanghai Municipality

Key details

Sponsor

Children's Hospital of Fudan University

Enrollment target

~60 participants

Started

January 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

2 Years – 18 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.